Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes

• Manik Garg,
• Dominique-Laurent Couturier,
• Jérémie Nsengimana,
• Nuno A. Fonseca,
• Matthew Wongchenko,
• Yibing Yan,
• Martin Lauss,
• Göran B. Jönsson,
• Julia Newton-Bishop,
• Christine Parkinson,
• Mark R. Middleton,
• D. Timothy Bishop,
• Sarah McDonald,
• Nikki Stefanos,
• John Tadross,
• Ismael A. Vergara,
• Serigne Lo,
• Felicity Newell,
• James S. Wilmott,
• John F. Thompson,
• Georgina V. Long,
• Richard A. Scolyer,
• Pippa Corrie,
• David J. Adams,
• Alvis Brazma,
• Roy Rabbie

Affiliations

Manik Garg

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI)

Dominique-Laurent Couturier

Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way

Jérémie Nsengimana

University of Leeds School of Medicine

Nuno A. Fonseca

CIBIO/InBIO-Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Rua Padre Armando Quintas

Matthew Wongchenko

Oncology Biomarker Development, Genentech Inc.

Yibing Yan

Oncology Biomarker Development, Genentech Inc.

Martin Lauss

Lund University Cancer Center, Lund University

Göran B. Jönsson

Lund University Cancer Center, Lund University

Julia Newton-Bishop

University of Leeds School of Medicine

Christine Parkinson

Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust

Mark R. Middleton

Oxford NIHR Biomedical Research Centre and Department of Oncology, University of Oxford

D. Timothy Bishop

University of Leeds School of Medicine

Sarah McDonald

Department of Pathology, Cambridge University Hospitals NHS Foundation Trust

Nikki Stefanos

Department of Pathology, Cambridge University Hospitals NHS Foundation Trust

John Tadross

Department of Pathology, Cambridge University Hospitals NHS Foundation Trust

Ismael A. Vergara

Melanoma Institute Australia, The University of Sydney

Serigne Lo

Melanoma Institute Australia, The University of Sydney

Felicity Newell

QIMR Berghofer Medical Research Institute

James S. Wilmott

Melanoma Institute Australia, The University of Sydney

John F. Thompson

Melanoma Institute Australia, The University of Sydney

Georgina V. Long

Melanoma Institute Australia, The University of Sydney

Richard A. Scolyer

Melanoma Institute Australia, The University of Sydney

Pippa Corrie

Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust

David J. Adams

Experimental Cancer Genetics, The Wellcome Sanger Institute

Alvis Brazma

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI)

Roy Rabbie

Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust